All results
2 results for phase iii prospective double blind placebo controlled randomized study adjuvant
-
Piomic COMS_03
The purpose of this clinical trial is to evaluate the safety and effectiveness of the treatment with the COMS One device in subjects with refractory diabetic…
- Ages
- 22 Years - 90 Years
- Sexes
- All
-
Vasomune AV001-004
A Phase 2a, randomized, double-blind, placebo-controlled, multiple ascending dose study in patients who are hospitalized with presumed pneumonia requiring…
- Ages
- 18 Years - N/A
- Sexes
- All